Sanofi Target Genzyme More Attractive to Buyers With Unit Sales

Genzyme Corp., a takeover target of Sanofi-Aventis SA, expects to complete sales of its diagnostics and pharmaceutical-ingredients units by the end of the year.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.